Annual D&A:
$346.00K+$54.00K(+18.49%)Summary
- As of today, VKTX annual D&A is $346.00 thousand, with the most recent change of +$54.00 thousand (+18.49%) on December 31, 2024.
- During the last 3 years, VKTX annual D&A has risen by +$50.00 thousand (+16.89%).
- VKTX annual D&A is now at all-time high.
Performance
VKTX Depreciation & Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly D&A:
$114.00K+$2000.00(+1.79%)Summary
- As of today, VKTX quarterly D&A is $114.00 thousand, with the most recent change of +$2000.00 (+1.79%) on September 30, 2025.
- Over the past year, VKTX quarterly D&A has increased by +$27.00 thousand (+31.03%).
- VKTX quarterly D&A is now -19.72% below its all-time high of $142.00 thousand, reached on September 30, 2022.
Performance
VKTX Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM D&A:
$447.00K+$27.00K(+6.43%)Summary
- As of today, VKTX TTM D&A is $447.00 thousand, with the most recent change of +$27.00 thousand (+6.43%) on September 30, 2025.
- Over the past year, VKTX TTM D&A has increased by +$137.00 thousand (+44.19%).
- VKTX TTM D&A is now at all-time high.
Performance
VKTX TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
VKTX Depreciation & Amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +18.5% | +31.0% | +44.2% |
| 3Y3 Years | +16.9% | -19.7% | +51.5% |
| 5Y5 Years | +33.1% | +62.9% | +117.0% |
VKTX Depreciation & Amortization Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +18.9% | -19.7% | +58.3% | at high | +56.3% |
| 5Y | 5-Year | at high | +33.1% | -19.7% | >+9999.0% | at high | +117.0% |
| All-Time | All-Time | at high | >+9999.0% | -19.7% | >+9999.0% | at high | >+9999.0% |
VKTX Depreciation & Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | $114.00K(+1.8%) | $447.00K(+6.4%) |
| Jun 2025 | - | $112.00K(+0.9%) | $420.00K(+9.7%) |
| Mar 2025 | - | $111.00K(+0.9%) | $383.00K(+10.7%) |
| Dec 2024 | $346.00K(+18.5%) | $110.00K(+26.4%) | $346.00K(+11.6%) |
| Sep 2024 | - | $87.00K(+16.0%) | $310.00K(+4.7%) |
| Jun 2024 | - | $75.00K(+1.4%) | $296.00K(+0.7%) |
| Mar 2024 | - | $74.00K(0.0%) | $294.00K(+0.7%) |
| Dec 2023 | $292.00K(+0.3%) | $74.00K(+1.4%) | $292.00K(+0.7%) |
| Sep 2023 | - | $73.00K(0.0%) | $290.00K(-19.2%) |
| Jun 2023 | - | $73.00K(+1.4%) | $359.00K(+25.5%) |
| Mar 2023 | - | $72.00K(0.0%) | $286.00K(-1.7%) |
| Dec 2022 | $291.00K | $72.00K(-49.3%) | $291.00K(-1.4%) |
| Sep 2022 | - | $142.00K(>+9900.0%) | $295.00K(+29.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | $0.00(-100.0%) | $228.00K(-24.3%) |
| Mar 2022 | - | $77.00K(+1.3%) | $301.00K(+1.7%) |
| Dec 2021 | $296.00K(+6.9%) | $76.00K(+1.3%) | $296.00K(+1.7%) |
| Sep 2021 | - | $75.00K(+2.7%) | $291.00K(+1.7%) |
| Jun 2021 | - | $73.00K(+1.4%) | $286.00K(+1.8%) |
| Mar 2021 | - | $72.00K(+1.4%) | $281.00K(+1.4%) |
| Dec 2020 | $277.00K(+6.5%) | $71.00K(+1.4%) | $277.00K(+34.5%) |
| Sep 2020 | - | $70.00K(+2.9%) | $206.00K(+51.5%) |
| Jun 2020 | - | $68.00K(0.0%) | $136.00K(+100.0%) |
| Mar 2020 | - | $68.00K(>+9900.0%) | $68.00K(>+9900.0%) |
| Dec 2019 | $260.00K(>+9900.0%) | - | - |
| Jun 2013 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2013 | - | $0.00 | $0.00 |
| Dec 2012 | $0.00 | - | - |
FAQ
- What is Viking Therapeutics, Inc. annual D&A?
- What is the all-time high annual D&A for Viking Therapeutics, Inc.?
- What is Viking Therapeutics, Inc. annual D&A year-on-year change?
- What is Viking Therapeutics, Inc. quarterly D&A?
- What is the all-time high quarterly D&A for Viking Therapeutics, Inc.?
- What is Viking Therapeutics, Inc. quarterly D&A year-on-year change?
- What is Viking Therapeutics, Inc. TTM D&A?
- What is the all-time high TTM D&A for Viking Therapeutics, Inc.?
- What is Viking Therapeutics, Inc. TTM D&A year-on-year change?
What is Viking Therapeutics, Inc. annual D&A?
The current annual D&A of VKTX is $346.00K
What is the all-time high annual D&A for Viking Therapeutics, Inc.?
Viking Therapeutics, Inc. all-time high annual D&A is $346.00K
What is Viking Therapeutics, Inc. annual D&A year-on-year change?
Over the past year, VKTX annual D&A has changed by +$54.00K (+18.49%)
What is Viking Therapeutics, Inc. quarterly D&A?
The current quarterly D&A of VKTX is $114.00K
What is the all-time high quarterly D&A for Viking Therapeutics, Inc.?
Viking Therapeutics, Inc. all-time high quarterly D&A is $142.00K
What is Viking Therapeutics, Inc. quarterly D&A year-on-year change?
Over the past year, VKTX quarterly D&A has changed by +$27.00K (+31.03%)
What is Viking Therapeutics, Inc. TTM D&A?
The current TTM D&A of VKTX is $447.00K
What is the all-time high TTM D&A for Viking Therapeutics, Inc.?
Viking Therapeutics, Inc. all-time high TTM D&A is $447.00K
What is Viking Therapeutics, Inc. TTM D&A year-on-year change?
Over the past year, VKTX TTM D&A has changed by +$137.00K (+44.19%)